We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights Accenture, SAP, The Estee Lauder, CME Group, and Aon
Read MoreHide Full Article
For Immediate Release
Chicago, IL – June 7, 2022 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Accenture plc (ACN - Free Report) , SAP SE (SAP - Free Report) , The Estée Lauder Companies Inc. (EL - Free Report) ,CME Group Inc. (CME - Free Report) and Aon plc (AON - Free Report) .
Here are highlights from Monday’s Analyst Blog:
Top Analyst Reports for Accenture, SAP and Estee Lauder
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Accenture plc, SAP SE, and The Estée Lauder Companies Inc. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
Accenture shares have gained +9.3% over the past year, roughly in-line with the Zacks Consulting Services industry's gain of +10.2%, but magnitude better than the broader market's -3.7% decline. The Zacks analyst believes that the company has been steadily gaining traction in its outsourcing and consulting businesses.
The company has been strategically enhancing its cloud and digital marketing suite through buyouts and partnerships. The company's strong operating cash flow has helped it reward its shareholders in the form of dividend payments and share repurchases, and pursue opportunities in areas that show true potential.
However, On the flip side, pricing pressure due to significant competition from strong companies like Genpact, Cognizant and Infosys, remains a concern. Global presence exposes it to foreign currency exchange rate fluctuations. Buyout-related integration risks remain a concern.
SAP shares have declined -26.4% over the year-to-date basis against the Zacks Computer - Software industry's decline of -21.2%. The Zacks analyst believes that the company's weak uptake of software licenses and support offerings remains a headwind. Stiff competition and increasing costs to enhance cloud-based offerings is likely to exert pressure on the company's profitability at least in the near term.
Though suspension of Russian operations amid the ongoing Ukraine war is expected to affect both revenues and non-IFRS operating profit, the company reiterated its outlook for 2022. Nevertheless, the company's performance is gaining from strength in its cloud business, especially the new Rise with SAP solution. Momentum in SAP's Business Process Intelligence platform, particularly the S/4HANA solutions along with steady traction witnessed in SuccessFactors Employee Central, Ariba and Fieldglass, Qualtrics and other cloud-based offerings is noteworthy.
The Estée Lauder shares have outperformed the Zacks Cosmetics industry over the past two years (+31.0% vs. -10.2%). The Zacks analyst believes that the company is benefiting from its growing Skin Care portfolio. The company's strong presence in emerging markets has also been a driver.
Further, it has a robust online business and the company expects it to be a major growth engine for the upcoming few years. These upsides were visible in the company's third-quarter fiscal 2022 results, wherein the top and the bottom line rose year over year.
However, the company is battling pandemic-induced restrictions in the Asia/Pacific region. During the third quarter, organic sales fell in mid-single-digits in Mainland China, as a sharp decline in brick-and-mortar sales offset online growth. The company revised its fiscal 2022 outlook downward owing to the added headwinds affecting the fiscal fourth-quarter view.
Other noteworthy reports we are featuring today include CME Group Inc. and Aon plc.
Why Haven't You Looked at Zacks' Top Stocks?
Our 5 best-performing strategies have blown away the S&P's impressive +28.8% gain in 2021. Amazingly, they soared +40.3%, +48.2%, +67.6%, +94.4%, and +95.3%. Today you can access their live picks without cost or obligation.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
The Zacks Analyst Blog Highlights Accenture, SAP, The Estee Lauder, CME Group, and Aon
For Immediate Release
Chicago, IL – June 7, 2022 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Accenture plc (ACN - Free Report) , SAP SE (SAP - Free Report) , The Estée Lauder Companies Inc. (EL - Free Report) ,CME Group Inc. (CME - Free Report) and Aon plc (AON - Free Report) .
Here are highlights from Monday’s Analyst Blog:
Top Analyst Reports for Accenture, SAP and Estee Lauder
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Accenture plc, SAP SE, and The Estée Lauder Companies Inc. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today's research reports here >>>
Accenture shares have gained +9.3% over the past year, roughly in-line with the Zacks Consulting Services industry's gain of +10.2%, but magnitude better than the broader market's -3.7% decline. The Zacks analyst believes that the company has been steadily gaining traction in its outsourcing and consulting businesses.
The company has been strategically enhancing its cloud and digital marketing suite through buyouts and partnerships. The company's strong operating cash flow has helped it reward its shareholders in the form of dividend payments and share repurchases, and pursue opportunities in areas that show true potential.
However, On the flip side, pricing pressure due to significant competition from strong companies like Genpact, Cognizant and Infosys, remains a concern. Global presence exposes it to foreign currency exchange rate fluctuations. Buyout-related integration risks remain a concern.
(You can read the full research report on Accenture here >>>)
SAP shares have declined -26.4% over the year-to-date basis against the Zacks Computer - Software industry's decline of -21.2%. The Zacks analyst believes that the company's weak uptake of software licenses and support offerings remains a headwind. Stiff competition and increasing costs to enhance cloud-based offerings is likely to exert pressure on the company's profitability at least in the near term.
Though suspension of Russian operations amid the ongoing Ukraine war is expected to affect both revenues and non-IFRS operating profit, the company reiterated its outlook for 2022. Nevertheless, the company's performance is gaining from strength in its cloud business, especially the new Rise with SAP solution. Momentum in SAP's Business Process Intelligence platform, particularly the S/4HANA solutions along with steady traction witnessed in SuccessFactors Employee Central, Ariba and Fieldglass, Qualtrics and other cloud-based offerings is noteworthy.
(You can read the full research report on SAP here >>>)
The Estée Lauder shares have outperformed the Zacks Cosmetics industry over the past two years (+31.0% vs. -10.2%). The Zacks analyst believes that the company is benefiting from its growing Skin Care portfolio. The company's strong presence in emerging markets has also been a driver.
Further, it has a robust online business and the company expects it to be a major growth engine for the upcoming few years. These upsides were visible in the company's third-quarter fiscal 2022 results, wherein the top and the bottom line rose year over year.
However, the company is battling pandemic-induced restrictions in the Asia/Pacific region. During the third quarter, organic sales fell in mid-single-digits in Mainland China, as a sharp decline in brick-and-mortar sales offset online growth. The company revised its fiscal 2022 outlook downward owing to the added headwinds affecting the fiscal fourth-quarter view.
(You can read the full research report on The Estee Lauder here >>>)
Other noteworthy reports we are featuring today include CME Group Inc. and Aon plc.
Why Haven't You Looked at Zacks' Top Stocks?
Our 5 best-performing strategies have blown away the S&P's impressive +28.8% gain in 2021. Amazingly, they soared +40.3%, +48.2%, +67.6%, +94.4%, and +95.3%. Today you can access their live picks without cost or obligation.
See Stocks Free >>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.